Association between epidermal growth factor receptor mutation and improved survival in never-smokers with primary adenocarcinoma of the lung [13]

Chest

Volumn 127, Issue 6, 2005, Pages 2292-

  Altundag, Ozden ^a,d   Altundag, Kadri ^a   Morandi, Paolo ^b   Gunduz, Mehmet ^c  

^a HACETTEPE UNIVERSITY   (Turkey)

^b Department of Medical Oncology   (Italy)

^c OKAYAMA UNIVERSITY   (Japan)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; GEFITINIB; TUMOR MARKER;

CLINICAL FEATURE; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; LARGE CELL CARCINOMA; LETTER; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SEX DIFFERENCE; SURVIVAL; TREATMENT RESPONSE; ADENOCARCINOMA; CANCER STAGING; COMPARATIVE STUDY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; MALE; METABOLISM; MORTALITY; MUTATION; NOTE; PATHOLOGY; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SMOKING;

ADENOCARCINOMA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MUTATION; NEOPLASM STAGING; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SMOKING; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 21844451636     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.127.6.2292     Document Type: Article

References (7)

1. Nordquist LT, Simon GR, Cantor A, et al. Improved survival in never-smokers vs current smokers with primary adenocarcinoma of the lung. Chest 2004; 126:347-351
2. Hirsch FR, Varella-Garcia M, Bunn PA, et al. Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis. J Clin Oncol 2003; 21:3798-3807
3. Miller VA, Kris MG, Shah N, et al. Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small cell lung cancer. J Clin Oncol 2004; 22:1103-1109
4. Paez JG, Janne PA, Lee JC, et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 2004; 304:1497-1500
5. Lynch TJ, Bell DW, Sordella R, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 2004; 350:2129-2139
6. Sordella R, Bell DW, Haber DA, et al. Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways. Science 2004; 305:1163-1167
7. Cappuzzo F, Magrini E, Ceresoli GL, et al. Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancer. J Natl Cancer Inst 2004; 96:1133-1141